Overcoming Old in Age-Friendliness

Por Lindenberg, J., Westendorp, R.G.J.
Publicado no J Soc Work Pract (2015)

Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased?

Por Posthuma, W. F., Westendorp, R. G., Vandenbroucke, J. P.
Publicado em 1994

beta-Adrenergic receptors contribute to hypoxaemia induced vasodilation in man.

Por Blauw, G J, Westendorp, R G, Simons, M, Chang, P C, Frölich, M, Meinders, A E
Publicado em 1995

Impact of mild cognitive impairment on survival in very elderly people: cohort study.

Por Gussekloo, J., Westendorp, R. G., Remarque, E. J., Lagaay, A. M., Heeren, T. J., Knook, D. L.
Publicado em 1997

Prevalence of five common clinical abnormalities in very elderly people: population based cross sectional study

Por de Craen, A J M, Gussekloo, J, Teng, Y K O, Macfarlane, P W, Westendorp, R G J
Publicado em 2003

Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine.

Por Posthuma, E F, Westendorp, R G, van der Sluys Veer, A, Kluin-Nelemans, J C, Kluin, P M, Lamers, C B
Publicado em 1995

Mortality in former Olympic athletes: retrospective cohort analysis

Por Zwiers, R, Zantvoord, F W A, Engelaer, F M, van Bodegom, D, van der Ouderaa, F J G, Westendorp, R G J
Publicado em 2012

Diagnostic criteria for sarcopenia relate differently to insulin resistance

Por Bijlsma, A. Y., Meskers, C. G. M., van Heemst, D., Westendorp, R. G. J., de Craen, A. J. M., Maier, A. B.
Publicado em 2013

Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels

Por van Vliet, P, Westendorp, R G.J., Eikelenboom, P, Comijs, H C., Frölich, M, Bakker, E, van der Flier, W, van Exel, E
Publicado em 2009

Auditory rehabilitation of older people from the general population--the Leiden 85-plus study.

Por Gussekloo, Jacobijn, de Bont, L E, von Faber, M, Eekhof, J A, de Laat, J A, Hulshof, J H, van Dongen, E, Westendorp, R G
Publicado em 2003

Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort

Por Bijlsma, A. Y., Meskers, C. G. M., Ling, C. H. Y., Narici, M., Kurrle, S. E., Cameron, I. D., Westendorp, R. G. J., Maier, A. B.
Publicado em 2012

Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction

Por Talens, Rudolf P, Jukema, J W, Trompet, S, Kremer, D, Westendorp, R G J, Lumey, L H, Sattar, N, Putter, Hein, Slagboom, P E, Heijmans, B T
Publicado em 2012

NT-proBNP, blood pressure, and cognitive decline in the oldest old: The Leiden 85-plus Study

Por van Vliet, Peter, Sabayan, Behnam, Wijsman, Liselotte W., Poortvliet, Rosalinde K.E., Mooijaart, Simon P., de Ruijter, Wouter, Gussekloo, Jacobijn, de Craen, Anton J.M., Westendorp, R.G.J.
Publicado em 2014

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Por Brugts, J J, Yetgin, T, Hoeks, S E, Gotto, A M, Shepherd, J, Westendorp, R G J, de Craen, A J M, Knopp, R H, Nakamura, H, Ridker, P, van Domburg, R, Deckers, J W
Publicado em 2009

Non-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies

Por Trompet, S., Postmus, I., Slagboom, P. E., Heijmans, B. T., Smit, R. A. J., Maier, A. B., Buckley, B. M., Sattar, N., Stott, D. J., Ford, I., Westendorp, R. G. J., de Craen, A. J. M., Jukema, J. W.
Publicado no Eur J Clin Pharmacol (2015)

Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study

Por de Jong, L. W., van der Hiele, K., Veer, I. M., Houwing, J. J., Westendorp, R. G. J., Bollen, E. L. E. M., de Bruin, P. W., Middelkoop, H. A. M., van Buchem, M. A., van der Grond, J.
Publicado em 2008

Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non‐demented elderly population

Por van den Heuvel, D M J, Dam, V H ten, de Craen, A J M, Admiraal‐Behloul, F, Olofsen, H, Bollen, E L E M, Jolles, J, Murray, H M, Blauw, G J, Westendorp, R G J, van Buchem, M A
Publicado em 2006

Genomics of human longevity

Por Slagboom, P. E., Beekman, M., Passtoors, W. M., Deelen, J., Vaarhorst, A. A. M., Boer, J. M., van den Akker, E. B., van Heemst, D., de Craen, A. J. M., Maier, A. B., Rozing, M., Mooijaart, S. P., Heijmans, B. T., Westendorp, R. G. J.
Publicado em 2011

Diagnostic criteria for sarcopenia and physical performance

Por Bijlsma, A. Y., Meskers, C. G. M., van den Eshof, N., Westendorp, R. G., Sipilä, S., Stenroth, L., Sillanpää, E., McPhee, J. S., Jones, D. A., Narici, M. V., Gapeyeva, H., Pääsuke, M., Voit, T., Barnouin, Y., Hogrel, J. Y., Butler-Browne, G., Maier, A. B.
Publicado em 2013

Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism

Por Jansen, S. W., Akintola, A. A., Roelfsema, F., van der Spoel, E., Cobbaert, C. M., Ballieux, B. E., Egri, P., Kvarta-Papp, Z., Gereben, B., Fekete, C., Slagboom, P. E., van der Grond, J., Demeneix, B. A., Pijl, H., Westendorp, R. G. J., van Heemst, D.
Publicado no Sci Rep (2015)